| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/04/2004 | EP1296947B1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 02/04/2004 | CN1137134C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 02/03/2004 | US6686471 Process and intermediates for growth hormone secretagogues |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686336 N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 01/29/2004 | WO2003053337A3 Therapeutic compositions |
| 01/29/2004 | WO2003037912A3 Tri-, tetra-, and penta-peptides having antiangiogenic activity |
| 01/29/2004 | WO2002090503A3 Anti-microbial peptides and compositions |
| 01/29/2004 | US20040019083 Amino acid derivatives; antineoplastic agents |
| 01/29/2004 | US20040019017 Caspase inhibitor prodrugs |
| 01/29/2004 | US20040018986 Viricide against hepatitis virus |
| 01/29/2004 | US20040018985 Enhanced hematopoiesis |
| 01/29/2004 | US20040018961 Forming micelles in aqueous solution; adjustment pH; stabilization |
| 01/29/2004 | US20040018580 Serine protease complex; immobilization; anticancer, antitumor agents |
| 01/29/2004 | US20040018171 Biochemical conjugates comprising tumor necrosis factor or interferons and ligands of CD antigen receptors, used as anticarcinogenic agents |
| 01/28/2004 | EP1384725A2 Factor Xa inhibitors |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
| 01/28/2004 | EP1383792A2 Sh2 domain binding inhibitors |
| 01/28/2004 | EP1383790A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | CN1471538A Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 01/28/2004 | CN1471528A Pyrrolidine derivatives and their use as chymase inhibitor |
| 01/28/2004 | CN1471526A Dioxolane analogs for improved inter-cellular delivery |
| 01/28/2004 | CN1136227C Method for preparing and purifying N-alkylated aspartame derivatives |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/27/2004 | US6683648 Enzyme inhibitors such as 2s-(((dimethylamino)acetyl)amino)-n-(3-((((2-hydroxy-1,1 -dimethylethyl)amino)sulfonyl)(3-methyl butyl)amino)-2r-hydroxy-1s-(phenylmethyl)-propyl)-3,3-dimethyl butanamide, used for prohylaxis of viral diseases |
| 01/27/2004 | US6683210 Human t-cell leukemia/lymphoma virus, human immunodeficiency virus, and lymphadenopathy associated virus treatment |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683163 Monitoring angiogenesis factor |
| 01/27/2004 | US6683055 Guanidine or amidine termined peptides |
| 01/27/2004 | US6682898 Analyzing using phosphated tyrosine compound |
| 01/27/2004 | US6682753 Increasing the effective concentration of a gpe- related compound (glycyl-prolyl-glutamic acid) in the central nervous system of the mammal to promote weight gain having condition that leads to decrease weight gain or weight loss |
| 01/22/2004 | WO2004007661A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/22/2004 | WO2004007557A2 Tf antagonist |
| 01/22/2004 | WO2004007529A2 Iap binding compounds |
| 01/22/2004 | WO2004007527A2 Secreted proteins |
| 01/22/2004 | WO2004007427A1 N-methyl amino acids |
| 01/22/2004 | WO2004007417A1 Enzyme inhibitors |
| 01/22/2004 | WO2004006962A2 A tissue factor binding immunoconjugate comprising factor viia |
| 01/22/2004 | WO2004006866A2 Antifungal therapeutic targets |
| 01/22/2004 | WO2003076391A3 Urokinase inhibitors, production and use thereof |
| 01/22/2004 | WO2002092622A8 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors |
| 01/22/2004 | US20040015037 Radioactive member and method of making |
| 01/22/2004 | US20040014964 Vitronectin receptor antagonist pharmaceuticals |
| 01/22/2004 | US20040014940 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 01/22/2004 | US20040014803 Antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014677 Antiinflammatory agents; antihistamines; brain disorders; Alzheimer's disease; inflammatory bowel disorders; antiarthritic agents |
| 01/22/2004 | US20040014676 SRC kinase inhibitors useful for treating osteoporosis |
| 01/22/2004 | US20040014674 Gpe analogs |
| 01/22/2004 | US20040014673 Pharmaceutical composition comprising an analgesic peptide |
| 01/22/2004 | US20040014647 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them |
| 01/22/2004 | DE10230875A1 Tubulysin-Biokonjugate Tubulysin bioconjugates |
| 01/22/2004 | DE10230874A1 Neue Tubulysinanaloga New Tubulysinanaloga |
| 01/22/2004 | DE10230872A1 Verfahren zur Herstellung von substituierten Thiazol-2-ylmethylestern A process for the preparation of substituted thiazol-2-ylmethylestern |
| 01/22/2004 | CA2487378A1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/21/2004 | EP1381627A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 01/21/2004 | EP0981366B1 Selective mmp inhibitors having reduced side-effects |
| 01/21/2004 | EP0822260B1 Substance fa-70d, process for producing the same, and uses thereof |
| 01/21/2004 | EP0787009B1 Cancer inhibitory peptides |
| 01/21/2004 | EP0759772B1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 01/21/2004 | EP0667786B1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 01/21/2004 | CN1469871A Substituted dipeptides as growth hormone secretagogues |
| 01/21/2004 | CN1135237C Crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester from aqueous solution |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/20/2004 | US6680178 Solid support containing a fluorogenic-leaving group, such as 7-amino-4-carbamoylmethyl-coumarin (acc) linked to an amino acid or peptide; cleavage of the peptide by a protease results in liberation of the leaving group for quantitative analysis |
| 01/15/2004 | WO2004005330A1 Process for producing sugar peptide having asparagine sugar chain and the sugar peptide |
| 01/15/2004 | WO2004005328A2 Peptidomimetic compound useful as inhibitor of integrins |
| 01/15/2004 | WO2004005327A1 Novel tubulysin analogues |
| 01/15/2004 | WO2004005326A2 Tubulysin conjugates |
| 01/15/2004 | WO2004005324A2 Peptide composition for treatment of sexual dysfunction |
| 01/15/2004 | WO2004005313A2 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 01/15/2004 | WO2004005270A1 Aza-peptide epoxides |
| 01/15/2004 | WO2004005269A1 Method for producing substituted thiazol-2-yl methyl esters |
| 01/15/2004 | WO2004004753A1 Peptide having an immunoregulatory property and the composition of said peptide |
| 01/15/2004 | WO2004004752A1 Caspase 9 activation and uses therefor |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003053349A3 Inhibitors of hepatitis c virus |
| 01/15/2004 | WO2003051797A3 Small-molecule inhibitors of interleukin-2 |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010116 Comprises peptide for treating cancer, nervous system, autoimmune and arthritic disorders; high throughput assay; epitope mapping; drug design |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009966 Interleukin converting enzyme inhibitors |
| 01/15/2004 | US20040009925 Tetrapeptide stimulating the fuctional activity of hepatocytes, pharmacological substance on its basis and the method of its application |
| 01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
| 01/15/2004 | US20040009911 Hepsin substrates and prodrugs |
| 01/15/2004 | CA2822657A1 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 01/15/2004 | CA2491594A1 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 01/15/2004 | CA2491218A1 Caspase 9 activation and uses therefor |
| 01/14/2004 | EP1380591A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/14/2004 | EP1380590A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/14/2004 | EP1380582A1 FSH mimetics for the treatment of infertility |
| 01/14/2004 | EP1380570A1 Process for producing n-formylamino acid and utilization thereof |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |